| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/03009747509165257 |
| P8608 | Fatcat ID | release_mpj7l3k7ejg7vce6k6p7fejkxe |
| P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.3109/03009747509165257 |
| P698 | PubMed publication ID | 1198074 |
| P2093 | author name string | K. Koota | |
| H. A. Isomäki | |||
| O. Mutru | |||
| P2860 | cites work | Annals of the Rheumatic Diseases | Q4767876 |
| COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT. | Q33626235 | ||
| Aspirin and myocardial infarction in patients with rheumatoid arthritis | Q43699227 | ||
| Bacteriolytic and bactericidal activity of sera and synovial fluids in rheumatoid arthritis and in osteoarthritis. | Q54381745 | ||
| Survivorship and Death in Rheumatoid Arthritis | Q71439618 | ||
| Length of life and cause of death in rheumatoid arthritis | Q73268669 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| rheumatoid arthritis | Q187255 | ||
| rheumatology | Q327657 | ||
| P304 | page(s) | 205-208 | |
| P577 | publication date | 1975-01-01 | |
| P1433 | published in | Scandinavian Journal of Rheumatology | Q15767622 |
| P1476 | title | Death rate and causes of death in patients with rheumatoid arthritis | |
| Death Rate and Causes of Death in Patients with Rheumatoid Arthritis | |||
| P478 | volume | 4 |
| Q84281565 | A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis |
| Q68094986 | An epidemiological approach to the study of outcome in rheumatoid arthritis |
| Q74456133 | Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity |
| Q34897630 | Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study |
| Q44068950 | Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. |
| Q41117952 | Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine |
| Q71918197 | Chromosomal changes in rheumatoid arthritis patients treated with CPH82 |
| Q52871509 | Death certificate and mortality in rheumatoid arthritis. |
| Q44514814 | Death rate and causes of death in RA patients during a period of five years |
| Q33566590 | Dyslipoproteinaemia in a subset of patients with rheumatoid arthritis |
| Q40104345 | Dyslipoproteinaemia in patients with active, chronic polyarthritis. a study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test) |
| Q69601426 | Dyslipoproteinemia in juvenile rheumatoid arthritis |
| Q67478509 | Dyslipoproteinemia in the course of active rheumatoid arthritis |
| Q36736328 | Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis |
| Q44123361 | Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. |
| Q34986307 | Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. |
| Q39701538 | Epidemiological, sociological and environmental aspects of rheumatoid arthritis and osteoarthrosis |
| Q39540992 | Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis |
| Q54389817 | Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. |
| Q33563669 | Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis |
| Q41913707 | Long-term outcome of treating rheumatoid arthritis: results after 20 years |
| Q45004490 | Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation |
| Q33556875 | Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis |
| Q35554834 | Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study |
| Q39644827 | Neoplastic associations of rheumatic diseases and rheumatic manifestations of cancer. |
| Q41915915 | Polymorphism of the β3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine |
| Q33567063 | Secondary acute myeloid leukaemia with 7q- complicating azathioprine treatment for rheumatoid arthritis. |
| Q35915958 | Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa? |
| Q34485318 | Ten year mortality and causes of death in patients with rheumatoid arthritis |
| Q34275961 | The epidemiology of rheumatoid arthritis |
| Q73327826 | The incidence of cancer associated with the treatment of rheumatoid arthritis |
| Q33554543 | The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up |
| Q37717307 | The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis |
| Q70303813 | Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective |
| Q72650138 | Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis |
| Q58914847 | Vascular function and handgrip strength in rheumatoid arthritis patients |
| Q39609243 | What happens to patients with rheumatoid arthritis? The long-term outcome of treatment |
| Q70744513 | [Glomerular nephropathies in untreated rheumatoid arthritis. Review of the literature apropos of 2 cases] |
Search more.